Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Attovia Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-64.13	-60.9	-45.05
Depreciation & Amortization	0.9	0.8	0.31
Share-Based Compensation	-	2.39	1.39
Other Operating Activities	0.02	-1.76	3.07
Operating Cash Flow	-63.21	-59.2	-35.04
Capital Expenditures	-0.81	-2.31	-1.77
Change in Investments	-	-71.14	-38.03
Investing Cash Flow	-21.68	-73.46	-39.8
Share Issuance / Repurchase	-	142.01	82.92
Debt Issued / Paid	-	-	-0.17
Financing Cash Flow	-1.12	142.01	82.75
Net Cash Flow	-86.01	9.36	7.91
Free Cash Flow	-64.02	-61.51	-36.81
Free Cash Flow Margin	-4742.07%	-4556.44%	-